methamphetamine has been researched along with Astrocytoma, Grade IV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CapelĂ´a, T; Caramelo, F; Fontes-Ribeiro, C; Gomes, C; Silva, AP | 1 |
Kast, RE | 1 |
1 review(s) available for methamphetamine and Astrocytoma, Grade IV
Article | Year |
---|---|
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastoma.
Topics: Brain Neoplasms; Central Nervous System Stimulants; Drug Approval; Drug Synergism; Glioblastoma; Humans; Methamphetamine; Naltrexone; Narcotic Antagonists; Neovascularization, Pathologic; Quaternary Ammonium Compounds; United States; United States Food and Drug Administration; Vascular Endothelial Growth Factor A | 2009 |
1 other study(ies) available for methamphetamine and Astrocytoma, Grade IV
Article | Year |
---|---|
Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.
Topics: Antineoplastic Agents; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Chemotaxis; Doxorubicin; Glioblastoma; Humans; Methamphetamine; Methotrexate | 2014 |